| http://www.w3.org/ns/prov#value | - This year has been good for liver diseases, especially for HCV, worldwide as well as for HIV-NAT. In terms of HCV research and treatment, we are now embarking into a new exciting era that promises shorter treatment duration, fewer side effects/toxicities, and therapies consisting of all oral, direct-acting, powerful antiviral agents.
|
